RMD ResMed Inc.
—Mkt Cap: —P/E: —1d ago
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value12.95B USD
Revenue (TTM)3.91B USD
Gross Profit2.39B USD
Net Income (TTM)1.05B USD
Revenue/Share9.71 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees11.4K
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU000000RMD6
Valuation
P/E (Trailing)—
P/E (Forward)18.09
PEG1.36
EV/EBITDA8.94
EV/Revenue3.31
P/S8.63
P/B2.12
EPS (TTM)1.54
EPS (Forward)1.92
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin61.06%
Oper. Margin30.86%
EBITDA Margin37.07%
Profit Margin26.94%
ROE23.13%
ROA16.99%
Growth
Revenue Growth8.60%
Earnings Growth2.40%
Cash Flow & Leverage
Operating CF1.25B USD
CapEx (TTM)122.44M USD
FCF Margin16.61%
FCF Yield—
Net Debt-444.58M USD
Net Debt/EBITDA-0.31
Balance Sheet
Debt/Equity0.13
Current Ratio3.10
Quick Ratio1.83
Book Value/Sh16.36 AUD
Cash/Share2.55 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate2.40 AUD
Div. Yield1.12%
5Y Avg Yield0.85%
Payout Ratio23.01%
Ex-Div DateAug 19, 2026
Pay Date—
Splits
Last Split2:1
Split DateAug 12, 2010
Analyst Consensus
Rating1.5 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)40.86 AUD
Target Range34.38 AUD – 48.24 AUD
# Analysts13
Ownership
Shares Out.1.41B
Float573.29M
Insiders0.00%
Institutions9.72%
Technical
SMA 5031.81 AUD
SMA 20031.86 AUD
Beta0.75
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)974.12K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—